Ovid Therapeutics (OVID) Property, Plant & Equipment (Net) (2016 - 2026)

Ovid Therapeutics (OVID) Property, Plant & Equipment (Net) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Ovid Therapeutics 118.66 Mn -36.86 Mn - 217,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 217,000.00
Mar 31, 2026 217,000.00
Dec 31, 2025 252,000.00
Dec 31, 2025 252,000.00
Sep 30, 2025 269,000.00
Sep 30, 2025 269,000.00
Jun 30, 2025 285,000.00
Jun 30, 2025 285,000.00
Mar 31, 2025 346,000.00
Mar 31, 2025 346,000.00
Dec 31, 2024 433,000.00
Dec 31, 2024 433,000.00
Sep 30, 2024 509,000.00
Sep 30, 2024 509,000.00
Jun 30, 2024 618,000.00
Jun 30, 2024 618,000.00
Mar 31, 2024 686,000.00
Mar 31, 2024 686,000.00
Dec 31, 2023 769,000.00
Dec 31, 2023 769,000.00